Pacer Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$340M Sell
718,269
-43,208
-6% -$21.8M 0.95% 23
2025
Q4
$356M Sell
761,477
-149,619
-16% -$69.5M 0.91% 26
2025
Q3
$388M Buy
911,096
+896,437
+6,115% +$347M 0.98% 27
2025
Q2
$5.62M Sell
14,659
-1,336,274
-99% -$482M 0.01% 647
2025
Q1
$467M Buy
1,350,933
+1,329,618
+6,238% +$428M 1.09% 26
2024
Q4
$6.4M Buy
21,315
+6,798
+47% +$2.38M 0.01% 554
2024
Q3
$5.9M Hold
14,517
0.01% 602
2024
Q2
$4.66M Buy
14,517
+1,476
+11% +$480K 0.01% 603
2024
Q1
$4.35M Sell
13,041
-2,447
-16% -$748K 0.01% 606
2023
Q4
$4.19M Buy
15,488
+1,205
+8% +$298K 0.01% 609
2023
Q3
$3.51M Sell
14,283
-464
-3% -$127K 0.01% 517
2023
Q2
$4.48M Buy
14,747
+1,852
+14% +$515K 0.02% 542
2023
Q1
$3.4M Buy
12,895
+12,142
+1,612% +$3.08M 0.01% 622
2022
Q4
$181K Sell
753
-13,376
-95% -$3M ﹤0.01% 2270
2022
Q3
$2.6M Buy
14,129
+10,787
+323% +$2.15M 0.02% 411
2022
Q2
$562K Sell
3,342
-8,936
-73% -$1.92M ﹤0.01% 671
2022
Q1
$3.08M Sell
12,278
-5,903
-32% -$1.48M 0.03% 511
2021
Q4
$4.67M Buy
18,181
+1,744
+11% +$427K 0.05% 484
2021
Q3
$3.99M Sell
16,437
-61,661
-79% -$15.1M 0.05% 492
2021
Q2
$16.1M Buy
78,098
+29,177
+60% +$5.95M 0.23% 61
2021
Q1
$9.21M Buy
48,921
+1,323
+3% +$233K 0.16% 90
2020
Q4
$7.83M Sell
47,598
-6,327
-12% -$925K 0.15% 102
2020
Q3
$6.72M Buy
53,925
+26,856
+99% +$3.32M 0.14% 109
2020
Q2
$2.63M Buy
+27,069
New +$2.81M 0.05% 266
2020
Q1
Sell
-30,279
Closed -$4.48M 862
2019
Q4
$4.48M Sell
30,279
-1,029
-3% -$138K 0.2% 80
2019
Q3
$3.77M Buy
31,308
+4,244
+16% +$548K 0.08% 246
2019
Q2
$3.66M Buy
27,064
+3,037
+13% +$384K 0.09% 236
2019
Q1
$3.13M Buy
+24,027
New +$3.23M 0.09% 216
2018
Q4
Sell
-14,772
Closed -$2.06M 756
2018
Q3
$2.06M Buy
14,772
+1,996
+16% +$248K 0.08% 317
2018
Q2
$1.31M Buy
12,776
+2,232
+21% +$226K 0.06% 482
2018
Q1
$1.02M Buy
10,544
+1,232
+13% +$120K 0.06% 455
2017
Q4
$818K Buy
9,312
+2,304
+33% +$185K 0.06% 499
2017
Q3
$558K Sell
7,008
-85
-1% -$6.84K 0.05% 611
2017
Q2
$619K Buy
7,093
+548
+8% +$46.4K 0.06% 479
2017
Q1
$582K Buy
6,545
+209
+3% +$17.4K 0.07% 406
2016
Q4
$469K Buy
6,336
+5,486
+645% +$411K 0.07% 433
2016
Q3
$64K Sell
850
-10
-1% -$766 0.01% 993
2016
Q2
$66K Buy
860
+66
+8% +$5.21K 0.01% 1023
2016
Q1
$62K Buy
794
+26
+3% +$1.82K 0.01% 752
2015
Q4
$52K Buy
+768
New +$53.6K 0.01% 748
2013
Q4
$795K Buy
+10,835
New +$501K 0.19% 149

Other funds holding HCA

Pacer Advisors's HCA Position: Q1 2026 in Review

Pacer Advisors reduced its HCA Healthcare (HCA) stake by 5.7% in Q1 2026, selling an estimated $21.8M and leaving 718,269 shares worth $340M. The position accounts for 0.95% of the portfolio, ranked #23.

Pacer Advisors first reported a position in HCA in Q4 2013 and has held it in 41 quarters since. The position peaked at $467M in Q1 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Pacer Advisors held 718,269 shares of HCA Healthcare worth $340M as of Q1 2026.
  • Pacer Advisors sold 43,208 HCA Healthcare shares in Q1 2026, an estimated $21.8M.
  • HCA Healthcare made up 0.95% of Pacer Advisors's portfolio in Q1 2026, its #23 holding.
  • Pacer Advisors first reported a position in HCA Healthcare in Q4 2013 and has held it in 41 quarters since.
  • Pacer Advisors's HCA Healthcare position peaked at $467M in Q1 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.